Prothena News

Prothena Corp Analyst Ratings

BenzingaApr 10 13:25 ET

Prothena Corp Analyst Ratings

BenzingaMar 13 09:24 ET

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)

TipRanksMar 13 06:20 ET

Piper Sandler Reaffirms Their Buy Rating on Prothena (PRTA)

TipRanksMar 7 07:36 ET

Oppenheimer Cuts Prothena Price Target to $80 From $98, Maintains Outperform Rating

MT NewswiresFeb 20 08:42 ET

Buy Rating Affirmed on Prothena Amid Strong Pipeline Progress and Solid Financials

TipRanksFeb 18 23:45 ET

Prothena Corp Analyst Ratings

BenzingaFeb 16 12:41 ET

RBC Trims Price Target on Prothena to $35 From $36, Keeps Sector Perform, Speculative Risk

MT NewswiresFeb 16 08:16 ET

RBC Capital Reaffirms Their Hold Rating on Prothena (PRTA)

TipRanksFeb 16 07:40 ET

Promising Outlook for Prothena's Amyloidosis Treatments: Analyst Endorses Buy Rating

TipRanksFeb 16 06:25 ET

Prothena Corp Analyst Ratings

BenzingaJan 30 08:04 ET

Prothena Corp Analyst Ratings

BenzingaJan 25 11:50 ET

RBC Cuts Price Target on Prothena to $36 From $43, Calls Initial Data on PRX012 'Anticlimactic,' Keeps Sector Perform, Speculative Risk

MT NewswiresJan 25 08:03 ET

RBC Capital Remains a Hold on Prothena (PRTA)

TipRanksJan 25 07:28 ET

Buy Rating on Prothena's Stock Amid Early Positive Signals for Alzheimer's Drug PRX012

TipRanksJan 11 01:38 ET

Prothena (PRTA) Gets a Buy From Piper Sandler

TipRanksJan 10 07:18 ET

Cantor Fitzgerald Maintains Overweight on Prothena Corp, Lowers Price Target to $87

BenzingaJan 9 09:08 ET

Prothena Corp Analyst Ratings

BenzingaJan 9 09:07 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Prothena (PRTA), Johnson & Johnson (JNJ) and Zimmer Biomet Holdings (ZBH)

TipRanksJan 9 07:20 ET

Promising Alzheimer's Drug and Strong Financials Underpin Buy Rating for Prothena

TipRanksJan 8 19:35 ET